Company Data
Thiogenesis Therapeutics Corp.
Ticker
TTI:CA
Current Price
$0.74 1.37%
Market Cap
$34.3M
Price Target
Refer to Report
Volume
21.5K
52wk Range
$0.51 - $0.8
Overview
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.